Reckitt Bids Up Bayer With $1.4 Bil. Schiff Nutrition Offer
This article was originally published in The Tan Sheet
Reckitt Benckiser’s $1.4 billion offer to acquire Schiff Nutrition would be 23.5% higher than Bayer’s and more than an 80% premium over Schiff’s share price prior to the Bayer announcement. Gaining Schiff would expand Reckitt’s consumer health business beyond OTC drugs and represent its first supplement foray.